No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Scientific Studies of Physiomesh Polypropylene

Polypropylene failure has been confirmed by scientific studies conducted by US Government at the National Institute of health

Tuesday, July 17, 2018 - Hundreds of thousands of hernia sufferers have had their hernias repaired using the Ethicon Physiomesh Flexible Composite Mesh implanted during routine laparoscopic surgery. Almost immediately, Physiomesh patients started to report chronic, recurring pain, infections and inflammation, hernia recurrence and bowel obstruction caused by the device's malfunctioning.

Physiomesh is composed of a nonabsorbent, macroporous polypropylene mesh laminated between 2 polyglecaprone-25 films. Physiomesh is initially held in place with 2-4 minimal staples but over the long-term scar tissue develops from the inflammation created by the device's interwoven fibers and holds the device over the site of the hernia repair. Ethicon Physiomesh made from polypropylene shrinks, buckles, and become otherwise detached from its intended place over a hernia to reinforce laparoscopic hernia repair. When Physiomesh become detached it is free to travel and usually winds up in the lower abdomen causing painful and potentially deadly intestinal blockages. Physiomesh patients have required revision surgery to find and remove the device and to repair or remove the organ it has damaged.

Scientific studies using animal research conducted by the US Institute of Health recently came to the conclusion that polypropylene plastic degrades: "New Zealand White female breeder rabbits were implanted with polypropylene mesh, ADSC-fixed polypropylene mesh in the abdomen. After 4 weeks, adhesion was performed and the erosion of the mesh was evaluated. It was found that polypropylene mesh, ADSC-fixed polypropylene mesh all had different degrees of corrosion and adhesion, but polypropylene mesh was more corroded." Such a scientific conclusion can lead one to assume that Physiomesh failures are mainly due to polypropylene's rejection by the human body's natural response mechanisms. In response to these scientific studies and also to the unacceptably high number of revision surgeries needed to remove Physiomesh, Ethicon issued a voluntary and permanent market withdrawal of Phyiomesh Flexible Composite Hernia mesh. Physicians were ordered to immediately cease using Physiomesh and return all inventories to the company.

Polypropylene mesh has failed Ethicon and its parent company Johnson and Johnson in the past as well. Ethicon's transvaginal mesh, a mesh device similar to Physiomesh used to treat pelvic organ prolapse, caused women to experience excessive pain and bleeding leading some to experience permanent incontinence. Tens of thousands of women have sued and reached settlements against Johnson & Johnson for failing to adequately test the long-term complications of transvaginal mesh. Ethicon Physiomesh patients requiring revision surgery may consult with Physiomesh attorneys to determine if they qualify to file a claim.

Polypropylene's primary use is in the manufacture of single-use plastic bags. Although polypropylene is a strong and flexible material and used extensively in commercial packaging, its safety when placed within the human body is questionable. Most leading scientific studies indicate that the material degrades over time. Experts conclude that much more study is needed to determine whether or not the material is safe when used in medical devices.

Sources:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450661/

https://www.meshmedicaldevicenewsdesk.com/what-do-we-know-about-polypropylene-2/

https://www.womenshealthmag.com/health/a19909024/transvaginal-mesh/

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.